The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae. 1998

J Rossjohn, and R J Gilbert, and D Crane, and P J Morgan, and T J Mitchell, and A J Rowe, and P W Andrew, and J C Paton, and R K Tweten, and M W Parker
The Ian Potter Foundation Protein Crystallography Laboratory, St. Vincent's Institute of Medical Research, 41 Victoria Parade, Fitzroy, Victoria, 3065, Australia. jamie@brains.medstv.unimelb.edu.au

Pneumolysin, a member of the thiol-activated cytolysin family of toxins, is a virulence factor from the Gram-positive bacterium Streptococcus pneumoniae. The toxin forms large oligomeric pores in cholesterol-containing membranes of eukaryotic cells. A plethora of biochemical and mutagenesis data have been published on pneumolysin, since its initial characterization in the 1930s. Here we present an homology model of the monomeric and oligomeric forms of pneumolysin based on the recently determined crystal structure of perfringolysin O and electron microscopy data. A feature of the model is a striking electronegative surface on parts of pneumolysin that may reflect its cytosolic location in the bacterial cell. The models provide a molecular basis for understanding the effects of published mutagenesis and biochemical modifications on the toxic activity of pneumolysin. In addition, spectroscopic data are presented that shed new light on pneumolysin activity and have guided us to hypothesise a detailed model of membrane insertion. These data show that the environment of some tryptophan residues changes on insertion and/or pore formation. In particular, spectroscopic analysis of a tryptophan mutant, W433F, suggests it is the residue mainly responsible for the observed effects. Furthermore, there is no change in the secondary structure content when the toxin inserts into membranes. Finally, the basis of the very low activity shown by a pneumolysin molecule from another strain of S. pneumoniae may be due to the movements of a key domain-domain interface. The molecular basis of pneumolysin-induced complement activation may be related to the structural similarity of one of the domains of pneumolysin to Fc, rather than the presumed homology of the toxin to C-reactive protein as previously suggested.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002942 Circular Dichroism A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Circular Dichroism, Vibrational,Dichroism, Circular,Vibrational Circular Dichroism
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D003603 Cytotoxins Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS. Cytolysins,Cytotoxic Agent,Cytotoxic Agents,Cytotoxin,Agent, Cytotoxic
D006460 Hemolysin Proteins Proteins from BACTERIA and FUNGI that are soluble enough to be secreted to target ERYTHROCYTES and insert into the membrane to form beta-barrel pores. Biosynthesis may be regulated by HEMOLYSIN FACTORS. Hemolysin,Hemolysins,Hemalysins,Proteins, Hemolysin

Related Publications

J Rossjohn, and R J Gilbert, and D Crane, and P J Morgan, and T J Mitchell, and A J Rowe, and P W Andrew, and J C Paton, and R K Tweten, and M W Parker
January 1997, Retina (Philadelphia, Pa.),
J Rossjohn, and R J Gilbert, and D Crane, and P J Morgan, and T J Mitchell, and A J Rowe, and P W Andrew, and J C Paton, and R K Tweten, and M W Parker
August 2020, The Journal of pharmacy and pharmacology,
J Rossjohn, and R J Gilbert, and D Crane, and P J Morgan, and T J Mitchell, and A J Rowe, and P W Andrew, and J C Paton, and R K Tweten, and M W Parker
July 1989, Infection and immunity,
J Rossjohn, and R J Gilbert, and D Crane, and P J Morgan, and T J Mitchell, and A J Rowe, and P W Andrew, and J C Paton, and R K Tweten, and M W Parker
October 2000, Journal of structural biology,
J Rossjohn, and R J Gilbert, and D Crane, and P J Morgan, and T J Mitchell, and A J Rowe, and P W Andrew, and J C Paton, and R K Tweten, and M W Parker
October 2022, Fitoterapia,
J Rossjohn, and R J Gilbert, and D Crane, and P J Morgan, and T J Mitchell, and A J Rowe, and P W Andrew, and J C Paton, and R K Tweten, and M W Parker
November 2000, Acta crystallographica. Section D, Biological crystallography,
J Rossjohn, and R J Gilbert, and D Crane, and P J Morgan, and T J Mitchell, and A J Rowe, and P W Andrew, and J C Paton, and R K Tweten, and M W Parker
January 2020, Evidence-based complementary and alternative medicine : eCAM,
J Rossjohn, and R J Gilbert, and D Crane, and P J Morgan, and T J Mitchell, and A J Rowe, and P W Andrew, and J C Paton, and R K Tweten, and M W Parker
November 2002, Infection and immunity,
J Rossjohn, and R J Gilbert, and D Crane, and P J Morgan, and T J Mitchell, and A J Rowe, and P W Andrew, and J C Paton, and R K Tweten, and M W Parker
October 2017, Journal of cellular and molecular medicine,
J Rossjohn, and R J Gilbert, and D Crane, and P J Morgan, and T J Mitchell, and A J Rowe, and P W Andrew, and J C Paton, and R K Tweten, and M W Parker
March 2008, The Journal of infectious diseases,
Copied contents to your clipboard!